Background: Rheumatoid arthritis (RA) is a systemic, debilitating and chronic inflammatory disorder affects 1% of the total world population. Due to absence of a defined aetiology and associated side effects of conventional medication has made obtaining permanent cure a challenge. Finding "one for all" cure is difficult due to genetic variations among populations. Deciphering genetic information, difference in regulatory network and epigenetic changes between populations can lead us to design a cure based on the principles of personalized medicine. Mitochondrial dysfunction, being a significant player in many autoimmune diseases, has also been accused for RA. Nucleotide changes can result in amino acid change, deletion or addition in enhancer, transcription factor or translation factor binding sites hampering overall function of mitochondria.
